ArticleMolecular cancer therapeutics2022

CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization.

Lisa Werr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.